Clinical Trials

Status
Title Intervention Sponsor Status
Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer Docetaxel, Paclitaxel, Quality-of-Life Assessment, Questionnaire Administration ECOG-ACRIN Cancer Research Group Active, not recruiting
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer Duloxetine, Duloxetine Hydrochloride, Oxaliplatin, Placebo, Quality-of-Life Assessment, Questionnaire Administration Alliance for Clinical Trials in Oncology Recruiting
Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer Interview, Questionnaire Administration Wake Forest University Health Sciences Active, not recruiting
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment Assessment of Therapy Complications, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration Children's Oncology Group Recruiting
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors Biospecimen Collection, Quality-of-Life Assessment, Questionnaire Administration ECOG-ACRIN Cancer Research Group Not yet recruiting
Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin Fat Emulsion, Placebo Mayo Clinic Active, not recruiting
Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment Quality-of-Life Assessment, Questionnaire Administration ECOG-ACRIN Cancer Research Group Active, not recruiting
Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II) Monosialotetrahexosylganglioside, Paclitaxel, Placebo Administration, Quality-of-life assessment, Questionnaire Administration Alliance for Clinical Trials in Oncology Recruiting
Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer Androgen deprivation therapy, Flibanserin 100 MG, Placebo Andrew McDonald Recruiting
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors Questionnaire Administration, Laboratory Biomarker Analysis Children's Oncology Group Recruiting